Dristhi Ragoonanan

463 total citations
23 papers, 144 citations indexed

About

Dristhi Ragoonanan is a scholar working on Oncology, Genetics and Neurology. According to data from OpenAlex, Dristhi Ragoonanan has authored 23 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Genetics and 5 papers in Neurology. Recurrent topics in Dristhi Ragoonanan's work include CAR-T cell therapy research (13 papers), Virus-based gene therapy research (6 papers) and Cancer Cells and Metastasis (4 papers). Dristhi Ragoonanan is often cited by papers focused on CAR-T cell therapy research (13 papers), Virus-based gene therapy research (6 papers) and Cancer Cells and Metastasis (4 papers). Dristhi Ragoonanan collaborates with scholars based in United States and Lebanon. Dristhi Ragoonanan's co-authors include Kris M. Mahadeo, Shulin Li, Richard Görlick, Jonathan Gill, Zhiliang Jia, Sajad Khazal, Priti Tewari, Natalie Dailey Garnes, Demetrios Petropoulos and Xueqing Xia and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dristhi Ragoonanan

20 papers receiving 143 citations

Peers

Dristhi Ragoonanan
Cristina F. Contreras United States
Dristhi Ragoonanan
Citations per year, relative to Dristhi Ragoonanan Dristhi Ragoonanan (= 1×) peers Cristina F. Contreras

Countries citing papers authored by Dristhi Ragoonanan

Since Specialization
Citations

This map shows the geographic impact of Dristhi Ragoonanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dristhi Ragoonanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dristhi Ragoonanan more than expected).

Fields of papers citing papers by Dristhi Ragoonanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dristhi Ragoonanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dristhi Ragoonanan. The network helps show where Dristhi Ragoonanan may publish in the future.

Co-authorship network of co-authors of Dristhi Ragoonanan

This figure shows the co-authorship network connecting the top 25 collaborators of Dristhi Ragoonanan. A scholar is included among the top collaborators of Dristhi Ragoonanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dristhi Ragoonanan. Dristhi Ragoonanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ragoonanan, Dristhi, Hisham Abdel‐Azim, Aditya Sharma, et al.. (2024). Retrospective analysis of veno-occlusive disease/sinusoidal obstruction syndrome in paediatric patients undergoing hematopoietic cell transplantation -a multicentre study. The Lancet Regional Health - Americas. 33. 100728–100728. 2 indexed citations
2.
Hu, Jiemiao, Alexander J. Lazar, Davis R. Ingram, et al.. (2024). Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models. Journal for ImmunoTherapy of Cancer. 12(1). e006991–e006991. 19 indexed citations
3.
Livingston, J. Andrew, Dristhi Ragoonanan, Priti Tewari, et al.. (2024). A first-in-human phase 1 trial of T cell membrane-anchored tumor targeted IL12 (ATTIL12) -T cell therapy in advanced/metastatic soft tissue and bone sarcoma.. Journal of Clinical Oncology. 42(16_suppl). TPS11586–TPS11586. 1 indexed citations
4.
Ragoonanan, Dristhi, Wafik Zaky, Sajad Khazal, et al.. (2023). Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option. SHILAP Revista de lepidopterología. 3(1). 37–56. 10 indexed citations
5.
Zaky, Wafik, Dristhi Ragoonanan, Izhar Singh Batth, et al.. (2023). Automated Capture and Analysis of Circulating Tumor Cells in Pediatric, Adolescent and Young Adult Patients with Central Nervous System Tumors. Cancers. 15(15). 3853–3853. 5 indexed citations
6.
Ragoonanan, Dristhi, Sajad Khazal, Kris M. Mahadeo, et al.. (2023). Prior COVID-19 infection may increase risk for developing endothelial dysfunction following hematopoietic cell transplantation. Frontiers in Oncology. 12. 1000215–1000215. 1 indexed citations
7.
Hu, Jiemiao, Alexander J. Lazar, Davis R. Ingram, et al.. (2023). Abstract 4102: attIL12-T cell therapy destructs cancer-associated fibroblasts and extracellular matrix in heterogenous osteosarcoma xenograft models. Cancer Research. 83(7_Supplement). 4102–4102. 1 indexed citations
8.
Ragoonanan, Dristhi, Priti Tewari, Demetrios Petropoulos, et al.. (2022). Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia. International Journal of Molecular Sciences. 23(15). 8748–8748. 3 indexed citations
9.
Ragoonanan, Dristhi, Sumit Gupta, Sajad Khazal, et al.. (2022). The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia. Biomedicines. 10(9). 2286–2286. 4 indexed citations
10.
11.
Jia, Zhiliang, Dristhi Ragoonanan, Kris M. Mahadeo, et al.. (2022). IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines. Frontiers in Immunology. 13. 952231–952231. 44 indexed citations
12.
Ragoonanan, Dristhi, Anna R. Franklin, Chandra Srinivasan, et al.. (2021). Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature. Cancers. 13(22). 5814–5814. 3 indexed citations
13.
Ragoonanan, Dristhi, César Núnêz, Michael Roth, et al.. (2021). DNMT3A Mutations Should be Considered in the Risk Stratification for Pediatric and Adolescent and Young Adult Patients with Acute Myeloid Leukemia. Blood. 138(Supplement 1). 1308–1308.
14.
Ragoonanan, Dristhi, Priti Tewari, Demetrios Petropoulos, et al.. (2021). Non‐myeloablative umbilical cord blood transplantation for atypical dyskeratosis congenita. Pediatric Transplantation. 26(2). e14157–e14157.
15.
Ragoonanan, Dristhi, Izhar Singh Batth, Arun Satelli, et al.. (2021). Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas. Frontiers in Oncology. 11. 760267–760267. 8 indexed citations
16.
Tambaro, Francesco Paolo, Dristhi Ragoonanan, Priti Tewari, et al.. (2021). The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients With Treatment-refractory Infections. Journal of Pediatric Hematology/Oncology. 44(2). e463–e466.
17.
Tambaro, Francesco Paolo, Sajad Khazal, César Núnêz, et al.. (2020). Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD‐19 chimeric antigen receptor T‐cell therapy. SHILAP Revista de lepidopterología. 8(9). 1678–1681. 7 indexed citations
18.
Ragoonanan, Dristhi, Sajad Khazal, Amanda B. Payne, et al.. (2020). Improved detection of sinusoidal obstructive syndrome using pediatric–AYA diagnostic criteria and severity grading. Bone Marrow Transplantation. 56(1). 175–184. 11 indexed citations
19.
Ragoonanan, Dristhi, David McCall, Basirat Shoberu, et al.. (2020). Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities. Frontiers in Oncology. 10. 1227–1227. 2 indexed citations
20.
Ragoonanan, Dristhi, et al.. (2020). The Organ Trail: A Review of Biomarkers of Organ Failure. Frontiers in Oncology. 10. 579219–579219. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026